BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31700983)

  • 1. Association of type 2 diabetes with central-scalp hair loss in a large cohort study of African American women.
    Coogan PF; Bethea TN; Cozier YC; Bertrand KA; Palmer JR; Rosenberg L; Lenzy Y
    Int J Womens Dermatol; 2019 Sep; 5(4):261-266. PubMed ID: 31700983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical and environmental risk factors for the development of central centrifugal cicatricial alopecia: a population study.
    Kyei A; Bergfeld WF; Piliang M; Summers P
    Arch Dermatol; 2011 Aug; 147(8):909-14. PubMed ID: 21482861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central hair loss in African American women: incidence and potential risk factors.
    Olsen EA; Callender V; McMichael A; Sperling L; Anstrom KJ; Shapiro J; Roberts J; Durden F; Whiting D; Bergfeld W
    J Am Acad Dermatol; 2011 Feb; 64(2):245-52. PubMed ID: 21075478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the severity of central centrifugal cicatricial alopecia.
    Suchonwanit P; Hector CE; Bin Saif GA; McMichael AJ
    Int J Dermatol; 2016 Jun; 55(6):e338-43. PubMed ID: 26769173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alopecia Areata on Vertex as a Potential Pitfall for Misdiagnosis of Central Centrifugal Cicatricial Alopecia in African-American Women.
    Johnson CM; Miteva M
    Int J Trichology; 2017; 9(2):73-75. PubMed ID: 28839392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central scalp alopecia photographic scale in African American women.
    Olsen EA; Callender V; Sperling L; McMichael A; Anstrom KJ; Bergfeld W; Durden F; Roberts J; Shapiro J; Whiting DA
    Dermatol Ther; 2008; 21(4):264-7. PubMed ID: 18715296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central Centrifugal Cicatricial Alopecia Presenting with Irregular Patchy Alopecia on the Lateral and Posterior Scalp.
    Miteva M; Tosti A
    Skin Appendage Disord; 2015 Mar; 1(1):1-5. PubMed ID: 27172374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hair breakage as a presenting sign of early or occult central centrifugal cicatricial alopecia: clinicopathologic findings in 9 patients.
    Callender VD; Wright DR; Davis EC; Sperling LC
    Arch Dermatol; 2012 Sep; 148(9):1047-52. PubMed ID: 22986858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hair transplantation in the surgical treatment of central centrifugal cicatricial alopecia.
    Callender VD; Lawson CN; Onwudiwe OC
    Dermatol Surg; 2014 Oct; 40(10):1125-31. PubMed ID: 25207763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating central centrifugal cicatricial alopecia and androgenetic alopecia in african american men: report of three cases.
    Davis EC; Reid SD; Callender VD; Sperling LC
    J Clin Aesthet Dermatol; 2012 Jun; 5(6):37-40. PubMed ID: 22768355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hair product use and breast cancer incidence in the Black Women's Health Study.
    Coogan PF; Rosenberg L; Palmer JR; Cozier YC; Lenzy YM; Bertrand KA
    Carcinogenesis; 2021 Jul; 42(7):924-930. PubMed ID: 34013957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central centrifugal cicatricial alopecia: past, present, and future.
    Gathers RC; Lim HW
    J Am Acad Dermatol; 2009 Apr; 60(4):660-8. PubMed ID: 19293013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central centrifugal cicatricial alopecia: what has been achieved, current clues for future research.
    Ogunleye TA; McMichael A; Olsen EA
    Dermatol Clin; 2014 Apr; 32(2):173-81. PubMed ID: 24680004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hair relaxers not associated with breast cancer risk: evidence from the black women's health study.
    Rosenberg L; Boggs DA; Adams-Campbell LL; Palmer JR
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1035-7. PubMed ID: 17507635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
    Kwon O; Senna MM; Sinclair R; Ito T; Dutronc Y; Lin CY; Yu G; Chiasserini C; McCollam J; Wu WS; King B
    Am J Clin Dermatol; 2023 May; 24(3):443-451. PubMed ID: 36855020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female pattern hair loss and its relationship to permanent/cicatricial alopecia: a new perspective.
    Olsen EA
    J Investig Dermatol Symp Proc; 2005 Dec; 10(3):217-21. PubMed ID: 16382668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hair loss: is there a relationship with hair care practices in Nigeria?
    Nnoruka EN
    Int J Dermatol; 2005 Oct; 44 Suppl 1():13-7. PubMed ID: 16187950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'A detective look' at hair biopsies from African-American patients.
    Miteva M; Tosti A
    Br J Dermatol; 2012 Jun; 166(6):1289-94. PubMed ID: 22348354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials.
    Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
    Br J Dermatol; 2020 Oct; 183(4):702-709. PubMed ID: 31970750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scarring Alopecia.
    Larrondo J; McMichael AJ
    Dermatol Clin; 2023 Jul; 41(3):519-537. PubMed ID: 37236719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.